Adjuvant Treatment of Early Stage Non–Small-Cell Lung Cancer
July 1st 1999Cure rates for non–small-cell lung cancer (NSCLC) remain low and the prognosis for patients with even stage IA disease is poor. Complete surgical resection is still the first-line treatment for NSCLC, but many investigators